Philips Sets May 8, 2026 AGM to Vote on Board, CEO Reappointment and Dividend
End of Quarter Sale - 50% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Koninklijke Philips ( (PHG) ) has provided an announcement.
Royal Philips has convened its 2026 Annual General Meeting of Shareholders, publishing the agenda and related materials ahead of the session scheduled for May 8, 2026, in Amsterdam. The AGM will vote on the 2025 financial statements, a cash-or-share dividend, the 2025 Remuneration Report on an advisory basis, and a new remuneration policy for the Supervisory Board.
Governance changes feature prominently, with shareholders asked to appoint U.S. executive John DeFord to the Supervisory Board and to reappoint Supervisory Board members Paul Stoffels, Herna Verhagen and Sanjay Poonen. The meeting will also vote on renewing CEO Roy Jakobs’ mandate as President, CEO, and Chairman of the Board of Management, signaling continuity in Philips’ leadership as it pursues its health‑technology strategy.
The most recent analyst rating on (PHG) stock is a Buy with a $29.00 price target. To see the full list of analyst forecasts on Koninklijke Philips stock, see the PHG Stock Forecast page.
Spark’s Take on PHG Stock
According to Spark, TipRanks’ AI Analyst, PHG is a Neutral.
PHG scores as moderately attractive, led by a clear 2025 profitability recovery and a supportive technical uptrend. The score is capped by multi-year earnings and cash-flow volatility and meaningful 2026 headwinds (tariffs and Respironics-related uncertainty), while the ~3% dividend provides some valuation support despite a negative P/E.
To see Spark’s full report on PHG stock, click here.
More about Koninklijke Philips
Royal Philips (Koninklijke Philips N.V.) is a Netherlands‑based health technology company focused on improving health and well‑being through patient‑ and people‑centric innovation. It is a global leader in diagnostic imaging, ultrasound, image‑guided therapy, monitoring, enterprise informatics and personal health, generating €18 billion in 2025 sales with about 64,800 employees in more than 100 countries.
Average Trading Volume: 987,644
Technical Sentiment Signal: Hold
Current Market Cap: $25.67B
See more data about PHG stock on TipRanks’ Stock Analysis page.
